First Wave BioPharma

Sanofi, drug repurposing, First Wave BioPharma, Alzheimer's disease, urinary incontinence, Capeserod

First Wave acquires Sanofi’s Alzheimer’s drug for GI disorders, retains buyback option

Anika Sharma

First Wave BioPharma has seized an opportunity from Sanofi to revive a long-dormant molecule, capeserod, by paying an upfront sum ...

latest News In Pharma

First Wave BioPharma’s Pancreatic Enzyme Replacement Therapy Faces Hurdles, Stock Plummets

SG Tylor

Source – First Wave BioPharma First Wave BioPharma, formerly known as AzurRx BioPharma, has faced ongoing challenges in bringing a ...